Abstract
Rabbit hyperimmune serum prepared to purified rat liver NADPH-cytochrome c rereductase (NADPH:cytochrome c oxidoreductase, EC 1.6.2.3) specifically inhibits the activity of this enzyme; thus, NADH-cytochrome c reductase was not affected. Measurement of the effects of the hyperimmune serum to NADPH-cytochrome c reductase on drug oxidation indicated that aminopyrine N-demethylation and aniline hydroxylation by rat liver microsomes from phenobarbital-treated animals, as well as benzpyrene hydroxylation by microsomes from 3-methylcholanthrene-treated animals, were inhibited. In addition, the activity of NADPH-cytochrome c reductase of normal, phenobarbital-treated, and 3-methylcholanthrene-treated rats was inhibited to the same extent by the γ-globulin fraction prepared from hyperimmune serum. Liver NADPH cytochrome-P-450 reductase of animals treated with phenobarbital was also inhibited by the antireductase globulin. The results indicate that the NADPH-cytochrome P-450 reductases involved in drug oxidation by liver microsomes from normal, phenobarbital-treated, and 3-methylcholanthrene-treated animals are similar.
- Copyright ©, 1971, by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
